Table 2.
Virus | Mechanism | References |
---|---|---|
HCMV | Downregulation of GLUT1 Upregulation of GLUT4 and glycolytic intermediates. Increase in lactate production Involvement of AMPK pathway |
[97,98,99,100,101] |
SARS-CoV2 | Induction and activation of HIF-1α Enhanced aerobic glycolysis |
[82] |
EBV | Upregulation of GLUT1, lactate dehydrogenase A, and PDK-1 LMP-1-induced expression of HIF-1α |
[104,105,106] |
KSHV | Induction and activation of HIF-1α Upregulation of GLUT3 and hexokinase II |
[94] |
NDV | Degradation of SIRT3 | [108,109] |
WSSV | Increased expression of hexokinase, phosphofructokinase, and AMPK Induction and activation of HIF-1α |
[110,111,112] |
GLUT: glucose transporter; AMPK: AMP-activated protein kinase; PDK-1: pyruvate dehydrogenase kinase 1; HIF-1α: hypoxia-inducible factor 1-alpha; LMP-1: latent membrane protein 1; SIRT3: sirtuin 3; HCMV: human cytomegalovirus; EBV: Epstein–Barr virus; KSHV: Kaposi´s sarcoma-associated herpesvirus; NDV: Newcastle disease virus; WSSV: white spot syndrome virus.